Zykadia (Ceritinib) Capsules


Medical Evidence zykadia
Generic name : Ceritinib.

Trade name : Zykadia.

Manufacturer information:

Zykadia is manufactured by Novartis Pharms Corp.

Zykadia FDA Approval :

Zykadia first approved April 29, 2014.

Zykadia Dosage form :

Capsules: 150 mg.

Zykadia Indications and Usage :

Non-Small Cell Lung Cancer

Indicated for anaplastic lymphoma kinase-positive metastatic non-small cell lung cancer (NSCLC) in patients who have progressed on or are intolerant to crizotinib.


Zykadia (Ceritinib) availability in India

  • You could import this medicine against import permit on Patient Name.
  • Please contact ACT Lifesciences Private Limited for further information.